Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.

Autor: Ng KYY; Division of Population Health and Integrated Care, Singapore General Hospital, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Teo AEK; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Tan SH; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tan JJE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tay DSH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee AWX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ang AJS; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Wong LWJ; Division of Pediatrics, KK Women and Children's Hospital, Singapore, Singapore., Choo SP; Curie Oncology, Singapore, Singapore., Toh HC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee SY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Tai DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.

Autor: Ng KYY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Tan JJE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tay DSH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee AWX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ang AJS; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Wong LWJ; Division of Pediatrics, KK Women and Children's Hospital, Singapore, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Curie Oncology, Singapore, Singapore., Tai DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.

Publikováno v: Liver cancer [Liver Cancer] 2021 Oct 26; Vol. 11 (1), pp. 9-21. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2022).